Back
Context Therapeutics Quote, Financials, Valuation and Earnings
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
66
CNTX
Context Therapeutics
Last Price:
2.26
Seasonality Move:
-23.73%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.Context Therapeutics Price Quote
$2.26
+0.01 (+1.8%)
(Updated: September 21, 2024 at 6:17 AM ET)
Context Therapeutics Key Stats
Buy
66
Context Therapeutics (CNTX)
is a Buy
Day range:
$2.23 - $2.50
52-week range:
$0.77 - $2.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.67%
Volume:
453K
Avg. volume:
91.3K
1-year change:
150%
Market cap:
$168.7M
Revenue:
$0
EPS:
$-1.06
How Much Does Context Therapeutics Make?
Data Unavailable
Is Context Therapeutics Growing As A Company?
Data Unavailable
Context Therapeutics Stock Price Performance
-
Did Context Therapeutics Stock Go Up Last Month?
Context Therapeutics share price went down by -10% last month -
Did CNTX's Share Price Rise Over The Last Year?
CNTX share price rose by 150% over the past 1 year
What Is Context Therapeutics 52-Week High & Low?
-
What Is Context Therapeutics’s 52-Week High Share Price?
Context Therapeutics has traded as high as $2.75 over the past 52 weeks -
What Is Context Therapeutics’s 52-Week Low Share Price?
Context Therapeutics has traded as low as $0.77 over the past 52 weeks
Context Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Context Therapeutics?
-
How Much Debt Does Context Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Context Therapeutics Have?
Cash and short term investments quarterly total is $101.5M -
What Is Context Therapeutics’s Book Value Per Share?
Book value per share is 1.35
Is Context Therapeutics Cash Flow Positive?
-
What Is CNTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$18.4M -
What Is Context Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Context Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Context Therapeutics Return On Invested Capital
Data Unavailable
Context Therapeutics Earnings Date & Stock Price
-
What Is Context Therapeutics's Stock Price Today?
A single share of CNTX can be purchased today for 2.25 -
What Is Context Therapeutics’s Stock Symbol?
Context Therapeutics trades on the nasdaq under the ticker symbol: CNTX -
When Is Context Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Context Therapeutics is scheduled on November 29, 2024 -
When Is CNTX's next ex-dividend date?
Context Therapeutics's next ex-dividend date is September 21, 2024 -
How To Buy Context Therapeutics Stock?
You can buy Context Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Context Therapeutics Competitors
-
Who Are Context Therapeutics's Competitors?
Below is a list of companies who compete with Context Therapeutics or are related in some way:
Context Therapeutics Dividend Yield
-
What Is CNTX Dividend Yield?
Context Therapeutics’s dividend yield currently is 0% -
What Is Context Therapeutics’s Payout Ratio?
Context Therapeutics’s payout ratio is 0% -
When Did Context Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is Context Therapeutics’s Dividend Per Share?
Context Therapeutics pays a dividend of $0.00 per share
Context Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 40% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 7.63 |
| Upside from Last Price: | 238.89% |